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Abstract
Background: All eukaryotes with the exception of plants use an actomyosin ring to generate a
constriction force at the site of cell division (cleavage furrow) during mitosis and meiosis. The
structure and filament forming abilities located in the C-terminal or tail region of one of the main
components, myosin II, are important for localising the molecule to the contractile ring (CR) during
cytokinesis. However, it remains poorly understood how myosin II is recruited to the site of cell
division and how this recruitment relates to myosin filament assembly. Significant conservation
between species of the components involved in cytokinesis, including those of the CR, allows the
use of easily genetically manipulated organisms, such as budding yeast (Saccharomyces cerevisiae), in
the study of cytokinesis. Budding yeast has a single myosin II protein, named Myo1. Unlike most
other class II myosins, the tail of Myo1 has an irregular coiled coil. In this report we use molecular
genetics, biochemistry and live cell imaging to characterize the minimum localisation domain (MLD)
of budding yeast Myo1.
Results: We show that the MLD is a small region in the centre of the tail of Myo1 and that it is
both necessary and sufficient for localisation of Myo1 to the yeast bud neck, the pre-determined
site of cell division. Hydrodynamic measurements of the MLD, purified from bacteria or yeast, show
that it is likely to exist as a trimer. We also examine the importance of a small region of low coiled
coil forming probability within the MLD, which we call the hinge region. Removal of the hinge
region prevents contraction of the CR. Using fluorescence recovery after photobleaching (FRAP),
we show that GFP-tagged MLD is slightly more dynamic than the GFP-tagged full length molecule
but less dynamic than the GFP-tagged Myo1 construct lacking the hinge region.
Conclusion: Our results define the intrinsic determinant for the localization of budding yeast
myosin II and show it to be an oligomer of tentatively 3 monomers. We suggest that this is the
minimum oligomeric unit (rather than the traditional myosin II dimer) that would allow specific
assembly to the site of cytokinesis in a manner similar to the full length molecule. The flexible hinge
region also contributes to CR structural integrity and contractility.
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Background
Budding yeast has one class II myosin, Myo1 [1,2], with
the classic myosin superfamily domain organisation con-
sisting of a conserved motor domain, a neck domain of 2
IQ motifs that binds the light chains Mlc1 and Mlc2 [3-5]
and a tail region with a predicted coiled coil, as seen for
all class II myosins so far studied. While the motor
domain is responsible for the actin binding and ATP
hydrolysis that allows the myosin to move along actin fil-
aments, the class II myosin tails are responsible for how
the motor function is used: the tails determine dimerisa-
tion, filament formation and localisation [6,7].
There are two potential ways in which class II myosins
may localise to the site of cell division: 1) by binding to
other proteins, as for example in fission yeast, (Schizosac-
charomyces pombe) where Mid1 is shown to temporally
regulate the localisation of the major class II myosin,
Myo2, [8]; 2) by filament formation, as shown in D. dis-
coideum where filament formation is required for myosin
II to localise to the cleavage furrow [9,10]. In non-muscle,
smooth muscle and D. discoideum myosin II, it has also
been shown that one or more small regions in the tail are
responsible for filament formation [7,9,11]. Filament for-
mation is thought to occur by the interaction of the
charged residues (exposed by coiled coil formation)
between two dimers. With the exception of fission yeast
Myp2, which has a discontinuous coiled coil and forms a
monomer [12], the class II myosins studied to date all
form dimers. In D. discoideum, filament formation also
depends on dephosphorylation of 3 serine residues [7,9].
It was also shown that dephosphorylation of Myo2 in fis-
sion yeast is necessary for localisation [8,13]. It should be
noted that higher eukaryotic class II myosins are also reg-
ulated by phosphorylation of their light chains but this
has not been demonstrated in D. discoideum or fission
yeast [7,14].
Very little is known about the structure of budding yeast
Myo1 and how it is recruited to the site of cell division.
Unlike higher eukaryotic class II myosins, Myo1 is not
predicted to consist of a continuous coiled coil as shown
in the PAIR COIL [15] prediction plot in Fig. 1. This raises
the question as to what kind of structure the Myo1 tail
forms and how this might affect its cellular function and
the structure of the contractile ring (CR). In order to deter-
mine if coiled coil formation is required for the localiza-
tion of budding yeast myosin II, we set out to map the
minimum domain in the tail region that is necessary and
sufficient for Myo1 localisation. We use hydrodynamic
measurements to assess its oligomeric nature and use
FRAP analysis to compare the in vivo dynamics of the min-
imum localisation domain with the full length molecule.
We also demonstrate that a region of low coiled coil form-
ing potential that we have named the hinge region is
important in the localisation and function of Myo1.
Results
A small region in the tail is sufficient for Myo1 localisation
In order to determine whether there is a discrete region of
Myo1 necessary and sufficient for localisation, deletion
constructs were created and transformed into wild type
and myoIΔ strains. The number of rings at the bud neck as
a percentage of the total number of bud necks was calcu-
lated for each construct in both wild-type and Δmyo1
strains and the results are shown in Fig 2, with fluorescent
microscopy images of GFP labelled Myo1 and MLD
shown below the localisation percentages. These results
show that the minimum localisation domain (MLD) con-
sists of residues 1044–1569. The coiled coil prediction
plot shows that the MLD (indicated in Fig. 1) encom-
passes the region of low coiled coil forming probability,
which includes 7 proline residues. Deletion of any addi-
tional parts of the MLD led to a lower percentage of local-
isation as compared to the full length MLD (Fig 2).
The minimum localisation domain (MLD) of Myo1 forms 
an oligomer
Since dimerisation and subsequently filament formation
in many class II myosins is required for localisation we
wanted to determine if the MLD forms oligomers. To this
end, GST-MLD was purified after expression in E. coli.
After removal of the GST tag, the MLD was applied to a
Superose 6 gel filtration column. The MLD eluted at 49.4
+/- 0.4 minutes (n = 7) and the Stokes radius was obtained
from a calibration curve of standards with known Stokes
radii as shown in Fig. 3a; this resulted in a Stokes radius of
8.4 +/- 0.7 nm for the MLD (Fig. 3a and 3c). The void vol-
ume for the column was obtained using Dextran blue
(2000 kDa, Stokes radius unknown), which gave an elu-
tion time of 32.2 minutes. Thyroglobulin, which has a
molecular weight of 669 kDa and an elution time of 49.0
minutes, ran close to the MLD, showing that the calibra-
tion curve was well within the upper resolution limit of
the column. Purified MLD was also applied to a pre-
formed 6–20 % sucrose density gradient and was found in
fraction 7.6 +/- 0.5 (n = 4). A sedimentation coefficient
obtained from a calibration curve of known sedimenta-
tion coefficients, as shown in Fig. 3b, was 5.2 +/- 0.3 S (n
= 4). Neither gel filtration nor sucrose density gradient
centrifugation can be used in isolation to obtain the
molecular weight of the MLD as the presumed elongated
nature of the protein will result in a larger apparent Stokes
radius and a smaller apparent sedimentation coefficient as
compared with a globular protein. This makes it difficult
to determine the true molecular weight and thus the oli-
gomeric nature of the MLD. However, combining the
Stokes radius and the sedimentation coefficient in Equa-
tion 1 (see Materials and Methods) allowed us to deter-BMC Biology 2006, 4:19 http://www.biomedcentral.com/1741-7007/4/19
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mine an experimental molecular weight of 177 kDa for
the MLD. When this value is divided by the calculated
molecular weight for a monomer (62 kDa), the oligomer
is tentatively assigned to be a trimer (2.9 monomers).
We were concerned that the experimental values obtained
were a product of expressing and purifying the MLD from
E. coli. In order to be sure that our expressed protein was
behaving in the same way as it would in yeast, the MLD
with a C-terminal (myc)6 tag was transformed into yeast
(RLY 1232). Yeast extracts were prepared by grinding fro-
zen cells under liquid nitrogen using a pestle and mortar;
the powder was resuspended in a small volume of buffer
and centrifuged to remove cellular debris and unlysed
cells. 250 μl of the supernatant was applied to the Super-
ose 6 gel filtration column. Fractions were collected and
western blots were carried out after trichloroacetic acid
(TCA) precipitation to determine the elution position of
MLD-(myc)6. As shown in Fig. 3c and 3d, MLD-(myc)6
eluted in the same fractions (48.2 +/- 0.4 minutes, n = 4)
as the expressed bacterial protein (49.4 +/- 0.4 minutes)
indicating that they are hydrodynamically similar and
thus that the trimer value assigned to MLD was not an
artefact of expression in E. coli.
Removing the MLD hinge region affects the function of 
Myo1
We observed that deletion of the MLD from Myo1
resulted in complete loss of localisation (Fig. 2) but that
deletion of the hinge region (residues 1162–1430) within
the MLD only lowered the efficiency of localisation to the
bud neck to 70 – 80 % of the full length molecule (Fig. 2)
showing that the hinge region contributes to localisation
but its loss does not abolish localisation. Since several
Paircoil analysis of Myo1 Figure 1
Paircoil analysis of Myo1. Coiled coil prediction of S. Cerevisiae Myo1 using the PAIRCOIL prediction program [15]. The 
black bar denotes the position of the MLD and the gray bar within the black bar denotes the position of the hinge region within 
the MLD. The dotted line is shown as a reference point for 50 % probability of coiled coil formation.
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other class II myosins contain kinks (where the coiled coil
heptad repeat is interrupted) in their tail that are impor-
tant for function, we wanted to examine the effect of
removing the hinge region from Myo1 on CR contraction.
A plasmid encoding Myo1Δhinge [Myo1(1–1161:1431–
1928)-GFP-(myc)6] under the control of the MYO1 pro-
moter was transformed into the heterozygous diploid
myo1Δ strain (RLY621), and haploid strains straining
expressing Myo1Δhinge as the sole Myo1 were obtained
by sporulation and tetrad dissection.
Localisation of Myo1-GFP and deletion mutants in wild type and myo1 null yeast strains Figure 2
Localisation of Myo1-GFP and deletion mutants in wild type and myo1 null yeast strains. Budding yeast strains 
(MYO1 and myo1Δ) were transformed with Myo1 constructs tagged with GFP as shown here schematically. Fluorescence 
microscopy was used to quantify the number of fluorescent bud necks as a percentage of the total number of bud neck and 
these numbers are given on the right. Fluorescence microscopy images of budding yeast cells labeled with Myo1-GFP and MLD-
GFP are shown below the localisation percentages. Scale bar denotes 5 μm.
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We monitored contraction of the CR in wild-type and
Myo1Δhinge strains. Cells were grown at the room tem-
perature and arrested for 3 hrs with nocodazole. The cells
were then released from arrest and contraction was moni-
tored using time-lapse confocal microscopy with images
taken every 30 s. Fig. 4 shows montages (A) and kymo-
graphs (B) of the wild-type and Myo1Δhinge ring as it
goes through cytokinesis. Interestingly, Myo1Δhinge rings
were unable to undergo contraction: the rings remained
steadily at the bud neck until late in the cell cycle before
gradually disappearing without reduction in diameter (n
= 15). This was in contrast to the CR in wild-type cells,
which contracted to a point before disappearing (n = 15).
Fluorescence recovery after photobleaching (FRAP) studies 
of wild-type and mutant Myo1-GFP rings
Fluorescence recovery after photobleaching (FRAP) ena-
bles one to examine the dynamics of a fluorescently
Hydrodynamic analysis of Myo1 MLD Figure 3
Hydrodynamic analysis of Myo1 MLD A. Superose 6 gel filtration calibration curve with positions of protein standards of 
known Stokes radii shown. The dotted lines show the position of the Myo1 MLD with a measured Stokes radius of 8.4 nm. B. 
Sucrose density gradient calibration curve with the positions of protein standards of known sedimentation coefficients shown. 
The dotted lines show the position of Myo1 MLD with a measured sedimentation coefficient of 5.2 S. C. Coomassie Blue 
stained SDS-PAGE gel showing Superose 6 FPLC fractions of bacterially expressed MLD (after GST tag removal). Fractions 
were TCA precipitated before loading on the gel. Numbers to the left of the gel show molecular weight of markers (M). D. 
Western blot of Superose 6 FPLC fractions of MLD-(myc)6 yeast extract using anti-myc antibodies. Fractions were TCA pre-
cipitated before loading on the gel. Horizontal black marks and numbers to the left of the marks show molecular weight of 
markers (M).
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labelled molecular structure: fast recovery of the fluores-
cent signal indicates that there is a free pool of molecules
that interchange rapidly with the molecules in the
bleached area. We used FRAP to compare the in vivo
dynamics of GFP-tagged full length Myo1, MLD and
Myo1Δhinge [strains RLY1044, RLY1046 and RLY2139
(Table 2)]. Images were collected at 5 or 10 s intervals and
analysed for fluorescence recovery. Table 1 shows the
average percentage recovery and half time values.
Myo1Δhinge appeared to be the most dynamic, recover-
ing the greatest proportion of the bleached fluorescence
and having the smallest recovery half time. This suggests
that the contraction defect of the Myo1Δhinge could be
due to a structural abnormality causing the mutant
Myo1Δhinge molecules to be less well anchored within
the CR. The MLD on the other hand appears to have a
dynamic behaviour in between that of the full length mol-
ecule and Myo1Δhinge (Table 1) suggesting that the MLD
is sufficient for stable association with the CR, but that
other regions of Myo1 further stabilise the association.
Discussion
In the experiments described above, we have character-
ized the minimum domain required for targeting myosin-
II to the site of cell division in budding yeast. We show
that this domain can oligomerise and form what appears
to be trimers in solution and exhibits dynamics interme-
diate to those of the full length Myo1 molecule and Myo1
missing the region of low coiled coil forming probability
(Myo1Δhinge).
How feasible is it that Myo1 might form a trimer? Coiled
coils are a ubiquitous protein motif with the ability to
form many different kinds of structures depending on the
knobs-into-holes packing of the residues in the coiled coil
and how this is disrupted by the distribution of breaks
and stutters within the heptad repeat sequence [16]. The
formation of triple stranded coiled coils is not unusual
[16]; for example the influenza hemagglutinin protein
[17] and the bacteriophage T4 whisker proteins [18] form
parallel triple stranded coiled coils while the BAR domain
of proteins such as amphiphysin consists of an antiparal-
lel triple stranded coiled coil that dimerises [19]. Addi-
tionally trimers may be observed experimentally even
when they have a dimeric coiled coil prediction [20,21].
Kammerer et al [21] provide evidence for a 5 residue trim-
erisation motif (R- [ILVM]-X-X- [ILV]-E) in short coiled
coils. Interestingly two such motifs are present in the
Myo1 tail (RVKSLE and RLSAVE at residues 1377–1382
and 1575–1580 respectively), one at the C-terminal end
of the hinge region and one just beyond the C-terminal
end of the MLD. Furthermore, many of the a and d resi-
dues of the heptad repeat in the Myo1 tail as predicted by
either COILS [22,23] or PAIRCOIL [15] are asparginine,
threonine and serine residues which can be prevalent in
trimeric coiled coil structures [21].
In order to confirm the trimeric nature of the MLD, elec-
tron microscopy and analytical ultra centrifugation exper-
iments were performed. Preliminary electron microscopy
(EM) negative stain studies (in collaboration with D.
Hanein and L. Hazelwood – results not shown) of puri-
fied MLD show a variety of oligomers which vary in
length. Analytical ultra centrifugation experiments
showed only protein aggregation indicating an inherent
stickiness in the protein. Interestingly the elution peaks in
gel filtration and sucrose density gradient were well
defined and narrow (Figure 3b and 3c) indicating a single
species of oligomer and also suggesting that the condi-
tions necessary for EM or analytical centrifugation lead to
protein instability. We speculate that the coiled coil
domains present in the MLD are not long enough to cause
stable association but that the MLD may be a minimal oli-
gomerisation unit and possibly also a filament nucleation
unit. That the MLD represents a normal assembly compe-
tent form is supported by the FRAP data which shows that
Time-lapse imaging of the wild-type and Δhinge Myo1 ring  contraction Figure 4
Time-lapse imaging of the wild-type and Δhinge 
Myo1 ring contraction. Typical examples of Myo1-GFP-
(myc)6 (RLY1331) and Myo1Δhinge-GFP-(myc)6 (RLY2139) 
CR contraction as shown as a montage with images one 
minute apart (A) and as kymographs (B). Each horizontal 
line of the kymograph represents a time point of the image 
series with images taken at 30 s intervals, derived from a line 
drawn across the GFP signal at the bud neck (shown in the 
schematic below B). These lines are then stacked next to 
each other in chronological order to generate the kymo-
graph. In A, scale bars denote 5 μm.
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the structure formed by the MLD was dynamically similar
to that formed by full length Myo1 (Table 1). However
further understanding of the nature and minumum oli-
gomerisation unit (dimer or trimer) requires detailed
structural and biochemical analysis of the native Myo1. If
the trimeric nature suggested by our experiments of the
MLD are indeed a property of the full length molecule,
this would suggest a novel mode of contraction for the
budding yeast CR as a Myo1 trimer would have 3 motor
domains as compared with the two motor domains
present in a more conventional dimeric structure.
As well as containing a region in the tail necessary for fil-
ament formation, all non-muscle myosins also contain
tail sequences that disrupt the coiled coil formation and
cause the tail to kink or bend sharply [7]. In higher eukary-
otes bending at these sites is regulated by light chain phos-
phorylation, whereas in D. discoideum bending is
regulated by heavy chain phosphorylation. Phosphoryla-
tion causes the tail to bend into a folded conformation
that prevents filament formation [7]. We have shown that
the region of low coiled coil forming probability in Myo1,
termed the hinge, is important for CR contraction. The
FRAP data also show that fluorescence recovery of
Myo1Δhinge is faster than that of the wild-type molecule.
It is interesting that the MLD, which possesses the hinge
region, has a slower exchange half time than Myo1Δhinge,
suggesting that the hinge has a role in anchoring Myo1 in
the CR. Taken together these data suggest that removal of
the hinge prevents proper CR assembly, resulting in
reduced structural stability. The inability of the hingeless
CR to contract could either be due to a lack of force gener-
ation or due to rapid disassembly when under force. Inter-
estingly, Lord et al [24] have recently shown that the
motor domain of Myo1 is not necessary for contraction to
occur at the bud neck during cytokinesis in budding yeast,
though the rate of contraction is slower than wild type.
This suggests that there is an additional force generating
element in the budding yeast CR and that the Myo1 tail
may serve to guide this force. The hinge region may play a
direct role in linking the two force generating elements.
The additional force generating element acting alone in
the absence of Myo1 or in the presence of a defective
Myo1 could come from Chs2, the enzyme that synthesizes
and deposits chitin during cytokinesis and this synthetic
energy could be used to drive membrane closure
[1,25,26]. Normally this force would be coupled with the
force generated by Myo1 and we speculate that the tail of
Myo1 may interact directly with Chs2. Future studies will
examine the localisation of other bud neck components
in the presence of the MLD or the hingeless Myo1 to see if
their localisation is perturbed. This will further our under-
standing of the cytokinetic defects caused by the loss of
hinge in Myo1 and of how it interacts with other bud neck
components.
Finally, how does the MLD compare with the localisation
determinants of other class II myosins? In fission yeast
Myo2, the region required for localization is different: it
was shown that a small C-terminal domain is necessary
and sufficient for localisation to the contractile ring
[8,13]. Phosphorylation plays a regulatory role in Myo2
localisation, though there is disagreement over the exact
residues involved. There is also evidence that the very C-
terminus of budding yeast Myo1 is phosphorylated [27],
but the precise residues and function of this phosphoryla-
tion are not known. Our results showing localisation in a
Myo1 construct lacking the C-terminus (Myo1 1–1908,
Fig. 2) suggest that this phosphorylation would not be
required for Myo1 localisation.
It remains open whether myosin-II recruitment is medi-
ated by a specific interaction, with certain components of
the cell division site, or by an interaction that requires cer-
tain structural features of the myosin-II complex assem-
bly. Regardless, the MLD can be used as bait for the
identification of the binding partners responsible for the
recruitment of myosin-II to the bud neck. However, given
the potential requirement for structural determinants and
the fact that direct recruiting factors for myosin-II have yet
to be found, we speculate that recruitment of myosin-II
may be mediated by multiple low affinity interactions
that rely on structural assembly of the CR and may not be
detectable by conventional solution-based assays for pro-
tein interactions.
Conclusion
Our results show that a small defined region in tail of bud-
ding yeast myosin II, the MLD, is necessary and sufficient
for localisation. We show that when expressed in bacteria
or in yeast, this domain behaves like a trimer rather than
like the more traditional class II myosin dimer, raising the
possibility that if the trimeric nature holds for the full
length Myo1, the structure of the CR in budding yeast
Table 1: FRAP total fluorescence recovery and half times
Strain Construct in Δmyo1 background Percentage recovery (SD) Half time (SD), s Number of cells
RLY1044 Myo1-GFP-6myc 27 (11) 79 (44) 14
RLY1046 MLD-GFP-6myc 40 (14) 50 (38) 11
RLY2139 Myo1Δhinge-GFP-6myc 50 (18) 28 (18) 12BMC Biology 2006, 4:19 http://www.biomedcentral.com/1741-7007/4/19
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might be different than were it composed in part of a
dimeric myosin II. The similarity between the dynamics of
the MLD and full length budding yeast myosin II in vivo as
explored through our FRAP studies lends confidence that
the MLD assembly in vivo is structurally similar to that of
full length Myo1. We also show that the MLD encom-
passes a region of low coiled coil forming probability (the
hinge) which, when removed, does not abolish myosin II
localisation to the bud neck, the site of cell division, but
does prevent proper contraction of the CR during cytoki-
Table 2: Strains
Name Genotype Background Source
RLY261 MATa ura3-1 his3-11,15 leu2-3,112 trp1 ade2-1 bar1Δ W303a Elion Lab
RLY621 MATa/α ura3/ura3 his3/his3 leu2/leu2 trp1/trp1 myo1Δ::TRP1/MYO1 S288c Li Lab
RLY622 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 S288c Li Lab
RLY751 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1044–1928)-GFP:LEU2 (pNT13) W303a This work
RLY1034 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1044–1569)-GFP-6myc:LEU2 (pNT49) W303a This work
RLY1035 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1-GFP-6myc:LEU2 (pNT50) W303a This work
RLY1040 MATa/α ura3-1/ura3-1 his3-11,15/his3-11,15 leu2-3,112/leu2-3,112 trp1-1/trp1-1 ade2-1/ade2-1 bar1Δ/bar1Δ 
myo1Δ::TRP/MYO1
W303a This work
RLY1044 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1-GFP-6myc:LEU2 (pNT50) S288c This work
RLY1046 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1(1044–1569)-GFP-6myc:LEU2 (pNT49) S288c This work
RLY1051 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1 Δ pMYO1(1–1043)-GFP-6myc:LEU2 (pNT51) W303a This work
RLY1073 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1044–1253)-GFP-6myc:LEU2 (pNT62) W303a This work
RLY1074 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1261–1569)-GFP-6myc:LEU2 (pNT63) W303a This work
RLY1096 MATa/α ura3-1/ura3-1 his3-11,15/his3-11,15 leu2-3,112/leu2-3,112 trp1-1/trp1-1 ade2-1/ade2-1 bar1Δ/bar1Δ 
myo1Δ::TRP/MYO1 pMYO1(1-1902)-GFP-6myc:LEU2 (pNT66)
W303a This work
RLY1101 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1–1902)-GFP-6myc:LEU2 (pNT66) W303a This work
RLY1103 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ myo1Δ::TRP pMYO1(1–1902)-GFP-6myc:LEU2 
(pNT66)
W303a This work
RLY1119 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1044–1161)-GFP-6myc:LEU2 (pNT71) W303a This work
RLY1212 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1(1044–1928)-GFP-6myc:LEU2 (pNT76) S288c This work
RLY1288 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1161–1928)-GFP-6myc:LEU2 (pNT94) W303a This work
RLY1295 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(864–1161)-GFP-6myc:LEU2 (pNT96) W303a This work
RLY1295 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(864–1161)-GFP-6myc:LEU2 (pNT96) W303a This work
RLY1297 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1529–1928)-GFP:LEU2 (pNT40) W303a This work
RLY1298 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1(1529–1928)-GFP:LEU2 (pNT40) S288c This work
RLY1307 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1044–1430)-GFP-6myc:LEU2 (pNT110) W303a This work
RLY1308 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1044–1387)-GFP-6myc:LEU2 (pNT111) W303a This work
RLY1309 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1044–1314)-GFP-6myc:LEU2 (pNT112) W303a This work
RLY1310 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1(1044–1430)-GFP-6myc:LEU2 (pNT110) S288c This work
RLY1311 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1(1044–1387)-GFP-6myc:LEU2 (pNT111) S288c This work
RLY1312 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1(1044–1314)-GFP-6myc:LEU2 (pNT112 S288c This work
RLY1330 MATa/α ura3-1/ura3-1 his3-11,15/his3-11,15 leu2-3,112/leu2-3,112 trp1-1/trp1-1 ade2-1/ade2-1 bar1Δ 
myo1Δ::KAN/MYO1 pMYO1-GFP-6myc:LEU2 (pNT113)
W303a This work
RLY1331 MA/α ura3-1 his3-11 leu2-3,112 trp1-1 ade2-1 bar1Δ myo1Δ::KAN pMYO1-GFP-6myc:LEU2 (pNT113) W303a This work
RLY1577 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1044–1160:1431–1928)-GFP-6myc:LEU2 
(pNT121)
W303a This work
RLY1578 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1(1044–1160:1431–1928)-GFP-6myc:LEU2 (pNT121) S288c This work
RLY1591 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1 pMYO1(1161–1928)-GFP-6myc:LEU2 (pNT94) S288c This work
RLY1598 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ myo1Δ::TRP pMYO1-GFP-6myc:URA3 (pNT113) W303a This work
RLY1653 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ myo1Δ::TRP pMYO1-GFP-6myc:URA3 (pNT113) 
p:LEU2 (pRL304)
W303a This work
RLY1655 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ myo1Δ::TRP pMYO1-GFP-6myc:URA3 (pNT113) g 
pMYO1-GFP-6myc:LEU2 (pNT50)
W303a This work
RLY1657 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ myo1Δ::KAN pMYO1-GFP-6myc:URA3 (pNT113) 
pMYO1(1–1045:1570–1928)-GFP-6myc:LEU2 (pNT120)
W303a This work
RLY1659 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1–1045:1570–1928)-GFP-6myc:LEU2 
(pNT120)
W303a This work
RLY1660 MATα ura3 his3 leu2 trp1 myo1Δ::TRP1g pMYO1(1–1045:1570–1928)-GFP-6myc:LEU2 (pNT120) S288c This work
RLY2127 MATα ura3 his3 leu2 trp1 myo1Δ::TRP, pMYO1(1–1160:1431–1928)-GFP-6myc:LEU (pIL11) S288c This work
RLY2128 MATa ura3-1 his3-11,15 leu2-3,112 trp1-1 ade2-1 bar1Δ pMYO1(1–1160:1431–1928-GFP-6myc):LEU (pIL11) W303a This work
RLY2132 MATα ura3 his3 leu2 trp1 MLD-6myc:LEU (pIL13) S288c This work
RLY2139 MATa ura3 his3 leu2 trp1myo1Δ::TRP1 pMYO1(1–1160:1431–1928) -GFP-6myc:LEU (pIL11) S288c This workBMC Biology 2006, 4:19 http://www.biomedcentral.com/1741-7007/4/19
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nesis. We propose that this hinge region may interact
directly with other components of the CR and that its loss
leads to a more dynamic, less anchored molecule as
shown by the faster fluorescent turnover seen in our FRAP
studies in comparison with the MLD and full length pro-
tein.
Methods
Media and genetic manipulations
Yeast cell culture and genetic techniques were carried out
by methods described in [28]. Yeast extract, peptone, dex-
trose (YPD) contained 2% glucose, 1% yeast extract and
2% Bactopeptone (Difco Laboratories, Detroit, MI). Syn-
thetic complete (SC) media was prepared by the method
described [29].
Plasmid construction
The plasmid expressing Myo1-GFP-(myc)6 (pNT50) was
generated by excising MYO1 from a previously-described
plasmid encoding Myo1-GFP (pLP8 [30]) with PstI and
BamHI, and ligating it into PstI-BamHI-digested pRL304,
a pRS315-based vector for C-terminal tagging with a GFP-
(myc)6 fusion. To generate Myo1-GFP-(myc)6 in a
pRS316 (URA3)-based vector, the 7 kb fragment from
SalI-NotI digested pNT50 was ligated to SalI-NotI digested
pRS316, creating pNT113. To generate the plasmid that
expresses the C-terminal 884 amino acids of Myo1p under
the control of the MYO1 promoter with a C-terminal GFP
tag (pNT13), the sequence encoding the promoter region
and the first 1043 amino acids was excised from pLP8,
using PstI and BglII, and replaced with just the promoter
region (generated by PCR and digested with PstI and
BglII). The GFP tag of pNT13 was replaced with a GFP-
(myc)6 fusion by ligating the 1 kb fragment generated by
BamHI-NotI digest of pNT50 to BamHI-NotI digested
pNT13, creating pNT76. To create the plasmid expressing
Myo1(1044–1569), pNT13 was double digested with
BglII and HaeIII yielding a 1.6 kb fragment encoding
Myo1(1044–1569). pNT13 was digested with BamHI,
blunted and digested with BglII, to yield a 7 kb fragment
encoding the vector backbone, MYO1 promoter, and GFP.
Ligation of both fragments produced an in-frame fusion
of Myo1(1044–1569) and GFP (pNT43), which was then
excised using PstI and BamHI, and ligated into PstI-
BamHI-digested pRL304 to create Myo1(1044–1569)-
GFP-(myc)6 (pNT49). The sequence encoding
Myo1(1529–1928) was generated by PCR from yeast
genomic DNA and digested with BglII and BamHI (restric-
tion sites contained within the forward and reverse prim-
ers, respectively), and ligated to the 6.9 kb fragment
produced by BglII-BamHI double digest of pNT13, to gen-
erate Myo1(1529–1928)-GFP (pNT40). To create the
plasmid expressing Myo1(1–1043), pNT50 was double-
digested with BglII and BamHI, blunted and self-ligated
yielding an in-frame fusion of Myo1(1–1043) and GFP-
(myc)6 (pNT51). The sequence encoding Myo1(1044–
1253) was generated by digesting pNT43 with XbaI, blunt-
ing, and digesting with PstI, yielding a 0.9 kb fragment.
This fragment was ligated to pNT49 that had been
digested with BamHI, blunted, and digested with PstI, to
create Myo1(1044–1253)-GFP-(myc)6 (pNT62). pNT43
was digested with XbaI, blunted and digested with BamHI
to produce a 0.9 kb fragment encoding Myo1(1261–
1569). This was ligated to pNT49 that had been digested
with BglII, blunted, and digested with BamHI, to create
Myo1(1261–1569)-GFP-(myc)6 (pNT63). A construct
expressing Myo1 lacking the C-terminal 26 amino acids
was generated by utilizing an existing EcoRI site, as
described previously [27]. Briefly, MYO1, cloned PstI-
BamHI in the Bluescript vector (pLP9), was digested with
EcoRI to yield a 6 kb fragment encoding Myo1(1–1902).
This fragment was ligated to EcoRI-digested pRL164, a
pRS313-based vector for C-terminal GFP tagging, to gen-
erate pRL221. This plasmid was double-digested with
BglII and BamHI to generate a fragment encoding
Myo1(1044–1902), and this was ligated to BglII-BamHI
digested pNT50 to create Myo1(1–1902)-GFP-(myc)6
(pNT66). The sequence encoding Myo1(1044–1161) was
generated by PCR from yeast genomic DNA and digested
with BglII and BamHI (restriction sites contained within
the forward and reverse primers, respectively) and ligated
to the 6.9 kb fragment produced by BglII-BamHI double
digest of pNT13 to generate Myo1(1044–1163)-GFP
(pNT69). The GFP tag of pNT69 was replaced with a GFP-
(myc)6 fusion by ligating the 1 kb fragment generated by
BamHI-NotI digest of pRL304 to BamHI-NotI digested
pNT69, creating pNT71. The sequences encoding
Myo1(1160–1928), Myo1(1044–1430), Myo1(1044–
1387) and Myo1(1044–1314) were generated by PCR
from yeast genomic DNA, digested with BglII and BamHI
(restriction sites contained within the forward and reverse
primers, respectively) and ligated to the 7.3 kb fragment
produced by BglII-BamHI double digest of pNT76, to gen-
erate pNT94, pNT110, pNT111 and pNT112, respectively.
Similarly, the sequence encoding Myo1(864–1161) was
generated by PCR from yeast genomic DNA, digested with
BamHI (restriction site contained within the forward and
reverse primers) and ligated to the 7.3 kb fragment pro-
duced by BglII-BamHI double digest of pNT76, to generate
Myo1(864–1161)-GFP-(myc)6 (pNT96). To create a dele-
tion of the non-helical sequences within Myo1-tail,
pNT121 was constructed. Briefly, the sequence encoding
Myo1(1431–1928) was generated by PCR from yeast
genomic DNA, digested with BamHI (restriction site con-
tained within the forward and reverse primers) and
ligated to BamHI digested pNT71, to generate
Myo1(1044–1160:1431–1928)-GFP-(myc)6. Similarly,
the sequence encoding Myo1(1570–1928) was generated
by PCR from yeast genomic DNA, digested with BglII and
BamHI (restriction sites contained within the forward andBMC Biology 2006, 4:19 http://www.biomedcentral.com/1741-7007/4/19
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reverse primers, respectively) and ligated to BglII-BamHI
digested pNT50, to generate Myo1(1–1044:1670–1928)-
GFP-(myc)6 (pNT120). To create a deletion of the non-
helical region of the MLD in the full length Myo1, pIL11
was constructed. Briefly pNT121 was cut with PstI/BglII to
yield a ~7000 bp fragment encoding Myo1(1044–
1161:1439–1928). This fragment was ligated with a
~3300 bp fragment encoding Myo1 promoter -Myo1(1–
1043) cut with PstI/BglII from pLP8. To create a plasmid
(pIL10) encoding N-terminally tagged GST-MLD, a PCR
product encoding Myo1(1044–1559) was cut with
BamHI/EcoRI was ligated into pGEX6P1 that contains a
precision protease cleavage site between the GST and
MLD reading frames. To create an MLD construct C-termi-
nally tagged with (myc)6 for expression in yeast, a frag-
ment consisting of Myo1 promoter-Myo1(1044–1569)
was cut from pNT49 using PstI and BamHI and ligated
into pRL72 cut PstI/BamHI resulting in pIL13.
Quantification of Myo1-GFP and deletion construct bud 
neck localization
Exponentially growing cultures of cells expressing either
Myo1-GFP or a deletion construct were assessed for bud
neck localization using an Eclipse E800 microscope with
a 100/1.40 oil differential-interference contrast objective
(Nikon, Melville, NY). At least 100–200 live cells were
analyzed, and data shown are averages from at least 3
independent experiments. Images were collected with a
0.5 s exposure to fluorescent light filtered through an
EXHQ450/50 DM480 LP/BA465LP GFP filter set
(Chroma, Brattleboro, VT) with a cooled RTE/CCD 782Y
Interline camera (Princeton Instruments) using Meta-
Morph (Universal Imaging Corp., West Chester, PA).
RLY2127 and 2128 fluorescence was weak and could not
be collected using the method described above. Instead 20
z sections at 0.5 μm intervals were collected and decon-
volved as described below for the CR movies. RLY1044
and RLY1046 were also measured in this way to ensure
that counts were comparable with those obtained by the
first method (Results for RLY1044: 79 %. Results for
RLY1046: 75 %).
Fluorescence recovery after photobleaching (FRAP)
FRAP experiments were carried out using a 435 nm nitro-
gen pulsed Micropoint laser (Photonic Instruments Inc.,
St. Charles IL). Galvanometer based steering optics con-
trolled with MetaMorph software were used to position
the laser beam, which was focused into a diffraction-lim-
ited 0.7 μm spot using a Nikon 100× 1.4 N.A. objective
lens. Images were acquired every 5 or 10 s with a
Yokogawa spinning disc confocal microscope mounted
on a Nikon TE2000U stand and a Hamamatsu ORCA ER
cooled CCD. All measurements were done using Meta-
Morph and all data analysis was done using Excel (Micro-
soft). To analyse the data, the signal from the FRAPed bud
neck and a control bud neck (to check for bleaching) were
collected. Regression analysis to determine the half time
to maximum was done using a one-phase exponential
association function (Y = bottom + (top-bottom)·(1-exp
[-k·x]), where k is the rate constant and t1/2 is 0.69/k in
Prism (version 4.00; GraphPad).
Time-lapse imaging of CR contraction
For assaying CR contraction, cells were arrested in met-
aphase with nocodazole for 3 hrs at room temperature
and then released from the arrest. The released cells were
mounted on gelatine pads. Three dimensional (3D)
images and movies of RLY1331 and RLY2139 were col-
lected with the spinning disc confocal microscope
described above, imaging 12 sections in the z-plane with
a spacing of 0.5 μm, with exposures of 1 s. Each stack of z-
series images was deconvolved and rendered in to 3D
images and movies using MetaMorph (Universal Imaging
Corp., West Chester, PA).
Protein purification
Myo1 minimum localisation domain (MLD) tagged N-
terminally with GST (plasmid pIL10) was transformed
into BL21 cells and grown in 1.5 L cultures at 37°C until
an OD600 of 1–1.2. The temperature was reduced to 24°C
and IPTG was added to a final concentration of 50 μM
before growing the cultures for a further 4 hrs. The cells
were harvested and stored as pellets at -20°C. Pellets were
lysed in 25 % sucrose, 50 mM Tris HCl, pH 7.5, 500 mM
NaCl, 1 Roche inhibitor tablet per 50 ml solution, 2 mM
DTT. The lysate was centrifuged at 35,000 rpm for 30 min-
utes and the supernatant added to 800 μl Glutathione
Sepharose 4B (Amersham Biosciences) for 3 hrs at 4°C
with constant agitation. The resin was washed with 50 ml
buffer A+ Triton (500 mM NaCl, 50 mM Tris HCl pH 7.5,
1 mM DTT, 1 % Triton X-100) followed by 40 ml buffer A
(500 mM NaCl, 50 mM Tris HCl pH 7.5, 1 mM DTT). The
resin was resuspended in 300–500 μl buffer A and 30 μl
of GST tagged precision protease at 0.6 mg/ml was added.
Digestion was carried out overnight at 4°C and the super-
natant was removed after low speed centrifugation to pel-
let the resin.
Gel filtration analysis
A Superose 6 column (BioRad) was equilibrated in buffer
A. 250 μl of Glutathione sepharose purified MLD with the
GST tag removed was added and 0.5 ml fractions were col-
lected. Alternatively, 250 μl RLY2132 yeast grinding
extract (see below) was run over the column. For SDS-
PAGE analysis, 10 % TCA was added to each fraction,
incubated on ice for 30 minutes and centrifuged for 15
minutes. The pellets were resuspended in 30 μl SDS-load-
ing buffer and 5 μl 1 M non-pH'd Tris base. MLD-(myc)6
from yeast extract fractions run on the column was
detected by Western blotting using the anti-myc mono-BMC Biology 2006, 4:19 http://www.biomedcentral.com/1741-7007/4/19
Page 11 of 12
(page number not for citation purposes)
clonal antibodies, 9E-10. The column was calibrated with
globular proteins of known Stokes radii: Thyroglobulin –
669 kDa, 8.5 nm, Ferritin – 440 kDa, 6.1 nm, Catalase –
232 kDa, 5.2 nm, Aldolase 158 kDa, 4.8 nm. Dextran Blue
with a molecular weight of approximately 2000 kDa was
used to establish the void volume of the column.
Sucrose density centrifugation gradients
5 ml 6–20 % sucrose gradients were prepared in ultra clear
centrifuge tubes (Beckman) for the SWTi55 rotor (Beck-
man). The gradient was calibrated using protein standards
of known sedimentation coefficients: catalase – 232 kDa,
11.2 S, aldolase – 158 kDa, 7.3 S, BSA – 66 kDa, 4.6 S,
ovalbumin – 43 kDa, 3.6 S. The top 400 μl of the gradient
were removed and replaced with 300 μl Glutathione
sepharose 4B purified MLD, 5 μg of aldolase as an internal
control, sucrose to a final concentration of 6 % and water
to 400 μl. The gradient was centrifuged for 19 hrs at 40 k
rpm at 4°C. At the end of the run, the gradient was frac-
tionated from the top into 250 μl fractions. These were
TCA precipitated as described above.
Calculation of native molecular weight
The native molecular weight of the expressed MLD was
calculated using its Stokes radius measured by gel filtra-
tion and its sedimentation coefficient determined by
sucrose density gradient centrifugation using the follow-
ing equation 1 described in [31].
where  Sω20  is the sedimentation coefficient, Rs  is the
Stokes radius, Avogadro's number, N is 6.02 × 1023; vis-
cosity coefficient, n is 1×10-2 g s-1 cm-1; solution density, ρ
is 1 g cm-3 and partial specific volume,   is 0.71 cm3 g-1
(assumed to be that of an average soluble protein).
Yeast extracts
To prepare the yeast extracts used for gel filtration analy-
sis, small pellets were extruded through a syringe into N2
(l) creating cylindrical fragments that could then be
ground by pestle and mortar in the presence of N2 (l). The
powdered yeast was thawed and resuspended in buffer A.
Protease inhibitors (2 μg/ml Antipain, 2 μg/ml Leupeptin,
2 μg/ml Aprotinin, 2 μg/ml Pepstatin, 2 μg/ml Chymosta-
tin) and 1 mM PMSF were added to both buffers. Lysis was
checked using light microscopy. Thawed extracts were
centrifuged at 50 K rpm in a Sorvall RP120AT rotor for 30
minutes at 4°C.
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